|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.85 TWD | -0.53% |
|
+1.47% | +11.49% |
Sinphar Pharmaceutical Co.,Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was TWD 777.4 million compared to TWD 771.02 million a year ago. Net income was TWD 110.38 million compared to TWD 80.12 million a year ago.
Basic earnings per share from continuing operations was TWD 0.66 compared to TWD 0.48 a year ago. Diluted earnings per share from continuing operations was TWD 0.66 compared to TWD 0.48 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +11.49% | 196M | |
| +16.50% | 42.12B | |
| +20.78% | 21.72B | |
| +21.14% | 15.75B | |
| +23.69% | 14.89B | |
| +57.44% | 13.06B | |
| -0.05% | 6.79B | |
| -14.94% | 6.3B | |
| +20.03% | 6.05B | |
| -8.87% | 5.73B |
SINPHAR PHARMACEUTICAL CO.,LTD. 
